Empowering innovative therapies in respiratory care to reach patients faster
Respiratory diseases are among the most prevalent disease categories globally, encompassing a wide range of conditions including various chronic airway diseases, acute and chronic respiratory infections, and interstitial lung diseases. These conditions not only affect patients' respiratory function and quality of life, but may also trigger multi-system complications, imposing a heavy social and healthcare burden.
Guangzhou Evidence-Based Medicine Co., Ltd. has managed multiple respiratory disease clinical trial projects with extensive and professional operational experience. We maintain long-term collaborations with KOLs from respiratory medicine departments of multiple top-tier hospitals and possess abundant respiratory expert resources. We also maintain close partnerships with the Guangzhou Institute of Respiratory Health, leveraging its leading position in the domestic respiratory field to provide strong academic and clinical support for various projects.
Gynecological and reproductive system diseases are common and frequently-occurring conditions that severely affect women's physical and mental health as well as family quality of life. Clinically, they encompass various reproductive organ pathologies, endocrine disorders, and infertility. These conditions not only bring long-term physical pain and psychological stress to women, but reproductive disorders are directly related to family harmony and societal fertility levels.
Guangzhou Evidence-Based Medicine has accumulated rich clinical operational experience in the field of gynecology and reproductive medicine, with deep understanding of the special operational requirements for women's health projects, including but not limited to subject privacy protection and care mechanisms, reproductive endocrine indicator monitoring, and precise menstrual cycle management. We maintain close collaborations with gynecology and reproductive medicine centers of multiple top-tier hospitals nationwide, providing professional assurance for high-quality project delivery.
Pediatric diseases cover various infections, respiratory, neurological, endocrine, and rare genetic disorders during children's growth and development. Children are not "miniature adults"—their physiological functions and drug metabolism characteristics differ significantly from adults. Pediatric diseases not only directly affect children's current growth, development, and physical/mental health, but may also have profound impacts on their lifelong health trajectory, imposing enormous psychological and financial burdens on families.
Based on previous clinical trial operational experience in the pediatric field, Guangzhou Evidence-Based Medicine strictly adheres to the "patient- and family-centered" principle in protocol development and study execution. We have established child subject care and compliance management mechanisms to enhance trial participation, and maintain close collaborations with pediatric KOLs from multiple renowned children's hospitals and general hospitals nationwide, providing professional assurance for innovative pediatric drug development.
Malignant tumors are among the most critical diseases threatening human life and health globally, characterized by high incidence, high mortality, and complex disease types. Tumors not only severely impair patients' physical functions and cause great physical suffering, but their lengthy treatment cycles and high medical costs also place heavy economic and psychological burdens on patients' families and society.
Given the complex procedures, long cycles, multi-dimensional data collection, and multidisciplinary collaboration requirements of oncology and immunotherapy clinical trials, Guangzhou Evidence-Based Medicine provides customized clinical development plans, evaluates accelerated development pathways and risk response strategies, and collaborates with KOLs from oncology and surgical oncology departments of multiple top-tier hospitals to resolve R&D challenges through refined and professional operations.
Orthopedic and sports medicine-related diseases encompass various degenerative joint diseases, traumatic fractures, spinal disorders, and sports injuries, and are among the leading causes of disability and mobility limitations worldwide. These conditions not only cause long-term chronic pain and severely affect patients' motor function and daily living independence, but also pose certain challenges to the healthcare system with the aging population.
Guangzhou Evidence-Based Medicine has profound clinical trial operational expertise in orthopedics, spine, and sports medicine, with familiarity with the special evaluation criteria and imaging assessment requirements for orthopedic drug and medical device clinical trials. We have established robust collaboration networks with experts from orthopedics, sports medicine, and rehabilitation departments of renowned top-tier hospitals, facilitating efficient advancement from early exploration to post-marketing studies.
Cardiovascular diseases are among the leading causes of death globally. It is estimated that approximately 3.5 million people die from cardiovascular diseases annually in China, ranking first among all disease categories. Cardiovascular and cerebrovascular diseases often have insidious onset, long courses, and are prone to recurrent episodes. Severe adverse events such as myocardial infarction and stroke directly threaten patients' lives, imposing extremely heavy healthcare burdens on families and society.
Guangzhou Evidence-Based Medicine has a professional, patient-centered clinical trial team and extensive execution management experience in the cardiovascular field. Addressing operational pain points such as stringent subject screening, commonly set washout and run-in periods leading to high screening failure rates, we have established efficient precision screening and subject management mechanisms. We also have an extensive network of collaborative hospitals and maintain close partnerships with top experts in the cardiovascular field.
Digestive system diseases encompass organic and functional pathologies of the esophagus, gastrointestinal tract, liver, and gallbladder, and are among the most prevalent common and frequently-occurring diseases globally that severely affect patients' quality of life. They are often accompanied by long-term physical suffering such as abdominal pain, acid reflux, and dyspepsia. Some chronic liver diseases and intestinal inflammations are more prone to causing severe systemic complications. With changing lifestyles, the disease burden of metabolic liver diseases and functional gastrointestinal disorders is increasing, and there is an urgent clinical need for innovative drugs and therapies to improve patients' long-term prognosis.
Guangzhou Evidence-Based Medicine collaborates with experts and key opinion leaders in gastroenterology and hepatology to provide full-process solutions from early development strategy to mid-late stage execution, with profound practical expertise in the digestive and liver disease fields.
Deepening expertise in endocrine and metabolic chronic disease management and drug development
Endocrine and metabolic diseases are chronic systemic conditions with extremely high global prevalence, requiring long-term or even lifelong management. These diseases not only cause hormonal imbalance and metabolic disorders, but are also highly prone to triggering severe systemic target organ complications affecting the cardiovascular system, kidneys, nervous system, and fundus oculi, severely impacting patients' quality of life.
Leveraging an extensive endocrinology expert network, Guangzhou Evidence-Based Medicine precisely screens and expands into hospitals in second- and third-tier cities with abundant patient pools, overcoming common challenges such as fierce project competition and uneven geographic distribution of enrollment. Targeting the long-term medication characteristics of chronic diseases, we have established subject compliance management systems and rigorously scrutinize key quality control points such as patients' prior medication history, ensuring high-quality trial data and smooth project delivery.
Skin diseases are common and frequently-occurring conditions with extremely high global prevalence, encompassing immune-inflammatory, infectious, and pigment metabolism disorders. Most skin diseases are not directly life-threatening, but persistent skin lesions, severe itching, and pain not only cause long-term physical suffering for patients, but also frequently trigger appearance anxiety and "stigma" that impose serious psychological burdens, significantly reducing patients' quality of life.
Guangzhou Evidence-Based Medicine possesses rich project operational experience and expert resources. Given that dermatology projects heavily rely on subjective evaluations from trial participants, we have established rigorous data quality control and topical medication compliance management mechanisms.
Deepening expertise in proctological health and innovative integrated traditional Chinese and Western medicine therapies
Proctological diseases are extremely common clinical conditions, encompassing various perianal organic lesions and functional intestinal disorders. They often have long disease courses and are highly prone to recurrence. The pain, bleeding, and defecation disorders they cause not only bring direct physical suffering to patients, but also often lead to psychological burden due to the sensitivity of the affected area, severely interfering with daily social interaction and quality of life.
Guangzhou Evidence-Based Medicine has conducted multiple clinical studies on both pharmacological and non-pharmacological treatments in the proctology field. Addressing the high privacy protection requirements for subjects and the subjective nature of postoperative wound healing assessment in proctology projects, we have established standardized privacy management mechanisms and targeted evaluation systems. We also maintain close collaborations with multiple renowned proctology specialty hospitals and general hospital proctology departments nationwide to ensure high-quality project advancement.
Supporting clinical evaluation in urology and male reproductive system
Urological and male reproductive system diseases encompass prostate diseases, urinary tract stones, urinary tract infections, and andrological dysfunctions. In addition to causing abnormal urination and impaired physiological function, they often have certain negative impacts on patients' mental health, family harmony, and overall quality of life.
Guangzhou Evidence-Based Medicine collaborates with multiple renowned urology and andrology centers nationwide, establishing comprehensive subject care, privacy protection, and data quality control systems to provide professional and rigorous operational assurance for clinical evaluation.
Tackling neurological and psychiatric disorders and innovations in their clinical evaluation
Neurological and psychiatric disorders are characterized by high disability rates, long disease courses, and complex pathogenesis. They not only severely impair patients' cognitive, motor, and emotional regulatory functions, but also impose heavy long-term caregiving burdens and psychological stress on patients and their families due to insufficient public awareness.
Guangzhou Evidence-Based Medicine has deep understanding of the unique challenges faced by neurological and psychiatric projects. We have established rigorous subject tracking and loss-to-follow-up prevention management systems, implemented standardized assessments and consistency checks to minimize human bias, and maintain close collaborations with core researchers from neurology and psychiatric departments of multiple renowned hospitals nationwide, providing professional assurance for high-quality project delivery.
With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.